Cardea Bio

In a first for the graphene electronics industry, leading integrated device manufacturer Paragraf has acquired graphene biosensor market pioneer Cardea Bio to accelerate the mass production of a new generation of devices that will deliver real-time analysis in point-of-need tests in the agritech, healthcare and environmental monitoring spaces. We introduce a new paradigm in understanding how electronics and biology work together: the Biological Processing Unit, or BPU. Like a CPU or a GPU, a BPU is a type of microchip. What makes the BPU distinct is the integration of biological material with graphene, silicon, and other electronics materials. Cardea’s BPU™ platform consists of BPUs, hardware, software and wetware. The core of the BPU is made up of multiple Cardean Transistors™ - graphene-based biology-gated field-effect transistors.